However, by using the observed values EDD, SEP, and PW, we get LVM = 1 04 x [((EDDc + dEDD) + (SEPc + dsEP) + (PWC + dpw))3 -(EDDC + dEDD)3] -13 6 instead of the correct value. To determine how strongly LVM is influenced by the individual errors of the quantities EDD, SEP, and PW entering the formula, we analysed the relation between the independent variables dEDD, dsEp, dpw, and the dependent variable dLVM which is the difference between the true and the calculated LVM.
Results Figure 1 shows the influence of SEP and PW measurement inaccuracies on LVM. An overestimation of both SEP and PW of 5% leads to a LVM change of 8%. Figure 2 shows the influence of EDD and either SEP or PW inaccuracy. An In this study we showed how measurement inaccuracies of SEP, PW, and EDD influence LVM. Measurement inaccuracies of EDD influence LVM more than errors of SEP or PW because EDD appears twice in Devereux's formula. Echocardiographic measurement inaccuracies are unavoidable especially in elderly and obese subjects, a clinical situation commonly encountered in hypertensive patients. Although known for a long time,4 even the use of cross sectionally guided M mode echocardiography could not overcome this methodological problem: A recent study showed an intraobserver variability of 8-2% for SEP, 6-9% for PW and 2-3% for EDD when one investigator read 35 studies of hypertensive patients 1-2 weeks apart. 6 The same authors found an interobserver variability between two observers of 9-1% for SEP, 8 7% for PW, and 3 1% for EDD.6 As our graphs show, these inaccuracies in the measurement of SEP, PW, and EDD will result in "changes" of LVM in the range of 8% to 15%. This is equivalent to changes observed during antihypertensive therapy. 8 Because the calculation of LVM is already integrated into the software of the echocardiographic machine, clinicians are in danger of relying on this "measurement". We propose that those who use LVM determined by M mode echocardiography should be aware of its susceptibility to measurement inaccuracy, especially in clinical decision making and in monitoring regression and progression of LVM in an individual patient. 
